scispace - formally typeset
H

Harry Staines

Publications -  22
Citations -  389

Harry Staines is an academic researcher. The author has contributed to research in topics: Hazard ratio & Chest pain. The author has an hindex of 11, co-authored 22 publications receiving 352 citations.

Papers
More filters
Journal ArticleDOI

Low Levels of the Omega-3 Index are Associated with Sudden Cardiac Arrest and Remain Stable in Survivors in the Subacute Phase

TL;DR: The omega-3 index remained stable after an event of SCA and predicted the risk of VF, and also applied to the omega-6/omega-3 ratio and the arachidonic acid (AA)/EPA ratio.
Journal ArticleDOI

The long-term prognostic value of multiple biomarkers following a myocardial infarction.

TL;DR: In a patient population consisting of 298 subjects hospitalized with a MI, a multimarker approach with NT-proBNP, hsCRP, MMP-9, PAPP-A, MPO, sCD40L and FM rendered no additional prognostic information beyond conventionally used stratification tools in the acute phase.
Journal ArticleDOI

Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome

TL;DR: High levels of PTX3, D-dimer and BNP were found to be independent, long-term predictors of all-cause mortality in chest pain patients with a suspected ACS, and hsCRP and B NP also predicted future myocardial infarction.
Journal ArticleDOI

(n-3) Fatty Acid Content of Red Blood Cells Does Not Predict Risk of Future Cardiovascular Events following an Acute Coronary Syndrome

TL;DR: The omega-3 index was evaluated as a prognostic risk marker following hospitalization with an acute coronary syndrome and there was no significant reduction in risk for all-cause mortality, cardiac death, or MI with increasing values of the index.
Journal ArticleDOI

The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain

TL;DR: PTX3 is a new biomarker related to inflammation that, independently of BNP, strongly predicts long-term all-cause mortality in patients with acute chest pain and the combination of these two biomarkers enhances the prognostic value over either marker alone.